RAAP Policy Study: Medicare's "Maximum Fair Price" Is Not a Transferable Model for State Drug Pricing

WASHINGTON, Feb. 18, 2026 /PRNewswire/ -- As states explore new strategies to address prescription drug affordability, the Rare Access Action Project (RAAP) today released an issue paper warning ...
KXAN

RAAP Policy Study Release Solving for Access and Affordability: PDABs are Not the Answer

WASHINGTON, Aug. 6, 2025 /PRNewswire/ -- The Rare Access Action Project (RAAP), today released its policy study on Prescription Drug Affordability Boards (PDAB). RAAP has been clear for years that ...
MarketWatch

RAAP: Don't Punish Progress: Restoring Innovation for Rare Disease Patients Isn't a "Cost," It's a Moral Imperative

WASHINGTON, Nov. 11, 2025 /PRNewswire/ -- There are times when the often unfairly criticized Congressional Budget Office (CBO) gets in its own way in preserving its credibility. The CBO shot itself in ...
Yahoo Finance

RAAP Policy Study Release Solving for Access and Affordability: PDABs are Not the Answer

"RAAP is excited to release our study on PDABs. While the talking points sound good, theory has not matched reality and the implementation of PDABs has revealed difficulties in achieving its lofty ...